Johnson & Johnson (JNJ) Interest Expenses (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Interest Expenses came in at $272.0 million in Q1 2026, up 33.33% year-on-year from $204.0 million in Q1 2025, and up 27.1% quarter-over-quarter from $214.0 million in Q4 2025.

Johnson & Johnson (JNJ) Interest Expenses (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Interest Expenses across 18 years of filings, most recently posting $272.0 million for Q1 2026.

  • Interest Expenses for Q1 2026 came in at $272.0 million, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 29.23% YoY), and the FY2025 annual result was $971.0 million, up 28.61% from the prior year.
  • Interest Expenses came in at $272.0 million for Q1 2026 at Johnson & Johnson, up from $214.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $308.0 million in Q2 2025 to a low of $10.0 million in Q2 2022.
  • The 5-year median for Interest Expenses is $193.0 million (2024), against an average of $177.8 million.
  • Across the five-year window, Interest Expenses plunged 84.13% in 2022 and jumped 2020.0% in 2023, its largest moves.
  • Johnson & Johnson's Interest Expenses stood at $51.0 million in 2022, then surged by 196.08% to $151.0 million in 2023, then dropped by 9.27% to $137.0 million in 2024, then surged by 56.2% to $214.0 million in 2025, then rose by 27.1% to $272.0 million in 2026.
  • The last three Interest Expenses figures came in at $272.0 million (Q1 2026), $214.0 million (Q4 2025), and $245.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -225.15 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 272.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 657.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 240.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Novartis Ag 109.78 Bn 109.09 Bn - -343.00 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 272.00 Mn
Mar 29, 2026 272.00 Mn
Dec 28, 2025 214.00 Mn
Dec 28, 2025 214.00 Mn
Sep 28, 2025 245.00 Mn
Sep 28, 2025 245.00 Mn
Jun 29, 2025 308.00 Mn
Jun 29, 2025 308.00 Mn
Mar 30, 2025 204.00 Mn
Mar 30, 2025 204.00 Mn
Dec 29, 2024 137.00 Mn
Dec 29, 2024 137.00 Mn
Sep 29, 2024 193.00 Mn
Sep 29, 2024 193.00 Mn
Jun 30, 2024 270.00 Mn
Jun 30, 2024 270.00 Mn
Mar 31, 2024 155.00 Mn
Mar 31, 2024 155.00 Mn
Dec 31, 2023 151.00 Mn
Dec 31, 2023 151.00 Mn